Announce Date | 04/30/2025 |
EPS Normalized Actual | $1.9 (Beat by $0.02) |
EPS GAAP Actual | $1.9 (Beat by $0.02) |
Revenue Actual | $1.353B |
Revenue Surprise | Beat by $1353M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $7.35556 |
EPS GAAP Estimate | $7.35556 |
Revenue Estimate | $2.122199999B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 30.6286 | 19.95 | 29.53875 | 32.29962 | 5 |
Dec 2026 | 25.04668 | 24.39 | 22.29 | 27.64 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.9 | -0.48524 | 1.353B | 7.54% | -95.42M |
FQ4 2024 (Dec 2024) | 4.81 | -3.28333 | 1.632B | 1.46% | -528.4M |
FQ3 2024 (Sep 2024) | 5.94 | 5.94 | 1.889B | -5.56% | 1889M |
FQ2 2024 (Jun 2024) | 4.78 | 4.78 | 1.764B | -3.22% | 1764M |
FQ1 2024 (Mar 2024) | 16.93 | 16.93 | 1.251B | -8.24% | 1251M |
FQ4 2023 (Dec 2023) | 4.66 | 4.66 | 1.6082B | 8.19% | 1608.2M |
FQ3 2023 (Sep 2023) | 6.96 | 6.96 | 1.9941B | 9.15% | 1994.1M |
FQ2 2023 (Jun 2023) | 5.63 | 5.63 | 1.8208B | 9.84% | 1820.8M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
7.35556
Consensus Revenue Estimates
2.122199999B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 8.11531 | -- | 7.52113 | 8.50166 | 8 |
FQ2 2027 (Jun 2027) | 6.17952 | -- | 5.72707 | 6.47371 | 5 |
FQ1 2027 (Mar 2027) | 2.69064 | -- | 2.49364 | 2.81873 | 4 |
FQ4 2026 (Dec 2026) | 5.59 | -- | 5.27246 | 5.9418 | 5 |
FQ3 2026 (Sep 2026) | 7.91 | -- | 7.46067 | 8.40781 | 3 |
FQ2 2026 (Jun 2026) | 5.69 | -- | 5.36678 | 6.04809 | 3 |
FQ1 2026 (Mar 2026) | 2.48 | 23.39 | 2.33912 | 2.63608 | 5 |
FQ4 2025 (Oct 2025) | 8.86333 | 45.73 | 8.39646 | 9.26741 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.23B | -- | 2.1B | 2.31B | 6 |
FQ2 2027 (Jun 2027) | 2.05B | -- | 1.93B | 2.12B | 6 |
FQ1 2027 (Mar 2027) | 1.5B | -- | 1.42B | 1.56B | 6 |
FQ4 2026 (Dec 2026) | 2.32B | -- | 2.22B | 2.43B | 5 |
FQ3 2026 (Sep 2026) | 2.27B | -- | 2.17B | 2.38B | 4 |
FQ2 2026 (Jun 2026) | 2.21B | -- | 2.12B | 2.32B | 5 |
FQ1 2026 (Mar 2026) | 2.16B | 37.51 | 2.07B | 2.27B | 4 |
FQ4 2025 (Oct 2025) | 2.31B | 29.25 | 2.21B | 2.39B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.38524 | 1.9 | -0.48524 | -25.54% |
FQ4 2024 (Dec 2024) | 8.09333 | 4.81 | -3.28333 | -68.26% |
FQ3 2024 (Sep 2024) | 5.94 | 5.94 | 100% | |
FQ2 2024 (Jun 2024) | 4.78 | 4.78 | 100% | |
FQ1 2024 (Mar 2024) | 16.93 | 16.93 | 100% | |
FQ4 2023 (Dec 2023) | 4.66 | 4.66 | 100% | |
FQ3 2023 (Sep 2023) | 6.96 | 6.96 | 100% | |
FQ2 2023 (Jun 2023) | 5.63 | 5.63 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.45B | $1.35B | $-95.42M | -7.05% |
FQ4 2024 (Dec 2024) | $2.16B | $1.63B | $-528.4M | -32.38% |
FQ3 2024 (Sep 2024) | $0B | $1.89B | $1889M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.76B | $1764M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.25B | $1251M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.61B | $1608.2M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.99B | $1994.1M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.82B | $1820.8M | 100% |